Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Mojdeh Poul — FY2025 total compensation $9,375,551

Mojdeh Poul is President and Chief Executive Officer and Director of Integra Lifesciences Holdings Corp (IART). The company reported total compensation of $9,375,551 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$1,009,616
Bonus$350,438
Stock awards$5,219,868
Option awards$2,250,011
Non-equity incentive plan$174,563
Pension and non-qualified deferred compensation$0
All other compensation$371,056
Total$9,375,551

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Integra Lifesciences Holdings Corp filed April 6, 2026, accession 0000917520-26-000015.

03

Peer context

Peer-group chief executive median$11,382,152
Difference from that median$-2,006,601
Percentile within the disclosed peer group44th
Peers with a disclosed figure16

Medians and percentiles are computed across the peer group Integra Lifesciences Holdings Corp discloses in its own compensation disclosure.

04

The other named executive officers of Integra Lifesciences Holdings Corp

Named executive officerRoleFY2025 total
Mojdeh Poul this pagePresident and Chief Executive Officer and Director$9,375,551
Lea KnightExecutive Vice President and Chief Financial Officer$2,882,994
Michael McBreenExecutive Vice President, President, Codman Specialty Surgical$2,713,278
Robert Davis, Jr.Executive Vice President, President, Tissue Technologies$1,912,633
Harvinder SinghExecutive Vice President, President, International$1,625,444
Jan De WitteFormer President and Chief Executive Officer and Director$282,679

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Integra Lifesciences Holdings Corp compensation brief.

05

The company page

Mojdeh Poul's compensation sits inside Integra Lifesciences Holdings Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Integra Lifesciences Holdings Corp (IART) compensation brief